Vor Biopharma Inc.
Ticker: VOR
| Insider | Title |
|---|---|
| Amy Quinlan | Vice President of Finance |
| Andrew J. Schwab | 10% or greater ownership |
| Capital Healthcare Fund Lp Ra | Director, 10% or greater ownership |
| Capital Management, L.p. Ra | Director, 10% or greater ownership |
| Capital Nexus Fund, L.p. Ra | Director, 10% or greater ownership |
| Christopher Slapak | Chief Medical Officer |
| Daniella Beckman | Director |
| David Charles Lubner | Director |
| Eyal C. Attar | CHIEF MEDICAL OFFICER |
| Fouad Namouni | Director |
| Han Wook Choi | Chief Financial Officer |
| Joshua Resnick | Director |
| Kush Parmar | Director, 10% or greater ownership |
| Matthew R Patterson | Director |
| Nathan D. Jorgensen | CHIEF FINANCIAL OFFICER |
| Opportunities I (gp), Llc 5am | 10% or greater ownership |
| Opportunities I, L.p. 5am | 10% or greater ownership |
| Partners Vi, Llc 5am | 10% or greater ownership |
| Peter Kolchinsky | Director, 10% or greater ownership |
| Rajeev M. Shah | Director, 10% or greater ownership |
| Robert Ang | PRESIDENT AND CEO, Director |
| Sven Ante Lundberg | Director |
| Tirtha Chakraborty | CHIEF SCIENTIFIC OFFICER |
| Ventures Vi, L.p. 5am | 10% or greater ownership |